Biological Safety Testing Products And Services Market Trends and Insights: Global Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the biological safety testing products and services market from 2026–2035 with trusted insights from The Business Research Company
What growth pattern is forecast for the Biological Safety Testing Products And Services Market size between 2026 and 2035?
The biological safety testing products and services market has witnessed substantial growth in recent years. This market is set to increase from $6.12 billion in 2025 to $6.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. The expansion observed in the past can be ascribed to several factors, including the escalating production of vaccines and biologics, the enlargement of pharmaceutical manufacturing capabilities, more stringent regulatory examination of product safety, the wider embrace of cell and gene therapies, and the rise in clinical research operations.
The biological safety testing products and services market size is anticipated to experience substantial growth in the upcoming years, projected to reach $11.34 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period can be attributed to several factors including increasing demand for advanced biologics safety assays, rising investments in automated testing platforms, the expansion of gene and cell therapy pipelines, a growing need for faster release testing, and an increasing emphasis on contamination risk mitigation. Major trends expected in the forecast period encompass the increasing adoption of rapid microbial detection methods, rising demand for automated sterility testing systems, the growing use of PCR-based safety testing, the expansion of outsourced biological testing services, and an enhanced focus on regulatory-compliant testing solutions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp
Which Drivers Are Impacting Market Performance In The Biological Safety Testing Products And Services Market?
The increasing requirement for gene therapies is anticipated to drive the expansion of the biological safety testing products and services market in the future. Gene therapy represents a medical strategy that employs genes to address or avert illnesses through the replacement, alteration, or addition of defective genetic material. Greater investment and scientific inquiry into gene mutation, combined with favorable regulatory frameworks, further stimulate advancements and broaden the uses of gene therapies. Within gene therapy, biological safety testing products and services are crucial for guaranteeing that viral vectors and genetic components are free from contaminants and safe for application. As an illustration, a document released by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, indicated in January 2024 that the quantity of gene therapies undergoing Phase III clinical trials expanded by 10% in quarter four, 2023. This marked the initial quarterly rise of its kind since quarter three, 2022. Consequently, the rising demand for gene therapies acts as a primary catalyst for the market of biological safety testing products and services.
Which Segments Are Contributing To The Growth Of The Biological Safety Testing Products And Services Market?
The biological safety testing products and services market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Services
2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types
3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell
Subsegments:
1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents
2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers
3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services
Which Trends Are Shaping Activity Within The Biological Safety Testing Products And Services Market?
Leading enterprises within the biological safety testing products and services market are actively engaged in creating swift, animal-free methods for bacterial endotoxin detection, with the dual objective of improving patient safety and accelerating drug development processes. This novel strategy is designed to decrease the duration of testing and boost accuracy, all without incorporating animal-derived components. An illustrative example occurred in January 2024, when Charles River Laboratories International, a pharmaceutical and biotechnology firm based in the U.S., launched its Endosafe Trillium cartridge. This product utilizes recombinant technology to identify and measure endotoxins without relying on materials sourced from animals. It stands as the initial rapid animal-free bacterial endotoxin test, offering quicker processing times and eliminating the necessity for animal-based reagents, thereby contributing to environmental responsibility and ethical testing standards. The primary goal of this particular product is to deliver quick, precise outcomes, simultaneously diminishing dependence on the conventional Limulus amebocyte lysate (LAL) traditionally obtained from horseshoe crabs.
Who Are The Prominent Global Companies Shaping The Biological Safety Testing Products And Services Market Landscape?
Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Biological Safety Testing Products And Services Market?
North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Biological Safety Testing Products And Services Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp
Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company
Bioanalytical Testing Services Market Report 2026
Food Pathogen Safety Testing Equipment And Supplies Market Report 2026
Agriculture Biologicals Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
